MACHELLE MCDOWELL: Open Payments
NPI 1316950603 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$39,870 in 165 payments from 16 companies in 2025. Trend: 2023 $12,598 · 2024 $25,365 · 2025 $39,870
Speaker / faculty: $32,847Food & beverage: $4,932Travel & lodging: $2,092
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 49 | $32,353 |
| ABBVIE INC. | 70 | $5,882 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $381 |
| GENZYME CORPORATION | 7 | $324 |
| Janssen Scientific Affairs, LLC | 3 | $310 |
| Ardelyx, Inc. | 3 | $160 |
| Aimmune Therapeutics, Inc. | 2 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Janssen Research & Development, LLC | 1 | $54 |
| Lilly USA, LLC | 3 | $53 |
Products named: TREMFYA, SKYRIZI, STELARA, CREON, ENTYVIO, DUPIXENT, LINZESS, IBSRELA.
Industry payments across TX — which companies pay providers there.
